SCHEMBL6428646

SCHEMBL6428646

CC(NC(=O)c1ccc(Cl)cc1)c1ccc(OC(C)(C)C(=O)O)cc1

nearest known ligand 0.63

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
PPARA Q07869 5/20 0.63
PPARG P37231 4/20 0.63
FABP2 P12104 2/20 0.63
SLC22A12 Q96S37 1/20 0.63
MEN1 O00255 2/20 0.62
CYP1A2 P05177 2/20 0.62
CYP3A4 P08684 2/20 0.62
MAPT P10636 2/20 0.62
CYP2C19 P33261 2/20 0.62
KMT2A Q03164 2/20 0.62
CYP2D6 P10635 1/20 0.62
SMN1; SMN2 Q16637 2/20 0.59
ALDH1A1 P00352 1/20 0.59
PPARD Q03181 1/20 0.59
NR1H4 Q96RI1 1/20 0.53
CNR1 P21554 10/20 0.52
CNR2 P34972 5/20 0.52
USP2 O75604 1/20 0.50
ABCB11 O95342 1/20 0.50
LMNA P02545 1/20 0.50

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL1304554 0.89 PPARA (0.54) PPARAPPARGFABP2SLC22A12MEN1
SCHEMBL3687773 0.81 PTGER4 (0.56) PPARAPPARGFABP2SLC22A12MEN1
SCHEMBL10338889 0.81 UTS2R (0.64) MEN1CYP1A2MAPTCYP2C19KMT2A
Clofibric Acid SCHEMBL102826 0.79 PPARA (1.00) PPARAPPARGFABP2SLC22A12MEN1
SCHEMBL12166209 0.79 PPARA (0.69) PPARAPPARGFABP2SLC22A12MEN1
Clofibric Acid SCHEMBL2227936 0.79 PPARA (1.00) PPARAPPARGFABP2SLC22A12MEN1
SCHEMBL11237830 0.78 HPGD (0.44) PPARAPPARGFABP2SMN1; SMN2ALDH1A1
Fenirofibrate SCHEMBL29024472 0.78 PPARA (0.78) PPARAPPARGFABP2SLC22A12MEN1
Fenirofibrate SCHEMBL2733696 0.78 PPARA (0.78) PPARAPPARGFABP2SLC22A12MEN1
SCHEMBL11569816 0.78 PPARA (0.68) PPARAPPARGFABP2SLC22A12MEN1

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 9 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-4370495-A Process for the preparation of α-[4-(4-chlorobenzoylaminoethyl)-phenoxy]-isobutyric acid BOEHRINGER MANNHEIM GMBH (DE) 1983-01-25 US claimed
JP-2005298392-A MEDICINAL COMPOSITION FOR PROPHYLAXIS OR TREATMENT OF REJECTION AFTER LIVER TRANSPLANTATION KISSEI PHARMACEUT CO LTD 2005-10-27 JP disclosed
WO-2004043951-A1 PYRAZOLE DERIVATIVES AS MODULATORS OF PEROXISOME PROLIFERATOR ACTIVATED RECEPTORS CAREX S.A. (FR) 2004-05-27 WO disclosed
JP-2004149489-A AGENT FOR PREVENTING AND TREATING INTRAHEPATIC STONE, OR AGENT FOR PREVENTING RELAPSE THEREOF KISSEI PHARMACEUT CO LTD 2004-05-27 JP disclosed
JP-2002249429-A THERAPEUTIC AGENT FOR CHRONIC HEPTITIS C KISSEI PHARMACEUT CO LTD 2002-09-06 JP disclosed
WO-2002067920-A1 REMEDIES FOR CHRONIC HEPATITIS C KISSEI PHARMACEUTICAL CO., LTD. (JP) 2002-09-06 WO disclosed
US-4370495-A Process for the preparation of α-[4-(4-chlorobenzoylaminoethyl)-phenoxy]-isobutyric acid BOEHRINGER MANNHEIM GMBH (DE) 1983-01-25 US disclosed
US-4370495-A Process for the preparation of α-[4-(4-chlorobenzoylaminoethyl)-phenoxy]-isobutyric acid BOEHRINGER MANNHEIM GMBH (DE) 1983-01-25 US disclosed
US-4370495-A Process for the preparation of α-[4-(4-chlorobenzoylaminoethyl)-phenoxy]-isobutyric acid BOEHRINGER MANNHEIM GMBH (DE) 1983-01-25 US disclosed